News

Norizite spray in bottle and box image

NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture

Thu, 15/12/2022 - 09:15
Image shows tree planters in high vis jackets holding two banners, one Watson and Marlow banner and one Veon banner

Watson-Marlow to create biodiverse native woodland in Ireland

Thu, 15/12/2022 - 07:30

BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis

Thu, 08/12/2022 - 07:30

MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease

Tue, 06/12/2022 - 07:30
Pharma Integrates speaker image

Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022

Mon, 05/12/2022 - 07:30

BRIM Biotechnology, Inc. raises $20 million in Series E funding round

Thu, 01/12/2022 - 08:30
LunaGel X-pure Ultrapure porcine skin image

Gelomics Partners With Rousselot Biomedical to Create the World’s First, Ready-to-Use 3D Cell Culture Kits Based on X-PURE® GelMA

Wed, 16/11/2022 - 07:30
Domainex restructuring team image

Domainex expands Executive and Management Teams to support ongoing growth

Tue, 15/11/2022 - 07:30

BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting

Tue, 01/11/2022 - 07:30
Image of Norizite 10ml and 20ml

New NoriZite™ Nasal Spray launches in the UK

Fri, 28/10/2022 - 07:30

Pages